The Equine Quarterly Disease Surveillance Report Q3 2024 produced by Equine Infectious Disease Surveillance, is now available. Some of the key updates included in the report are: NEWS: The Equine Industries Committee - Who, what, and why? NEWS: Strategies to monitor and combat parasite-related disease and anthelmintic resistance in horses FOCUS: An ongoing concern: Twenty years of research on equine atypical myopathy with a focus on UK surveillance data You will also be able to find EIDS’

The BEVA Sustainability Working Group have been developing guidelines on the use of equine endo- and ecto-parasite treatments, focusing on minimising their environmental impact. These expand on a number of recently published articles, including the CANTER guidelines for sustainable equine parasite control. The BEVA Guidelines will take the form of guidance for vets, a helpsheet for clients, and a number of additional resources. For more information in the meantime, take a look at the following:

Despite an investigation suggesting that by 2050, 10 million people might die annually because of antimicrobial resistance, public interest in the threat of the downfall of antibiotics appears limited, suggests Bruce Bladon, in the latest virtual issue of the Equine Veterinary Journal (EVJ). As guest editor of this issue, he has chosen 15 of the most pertinent articles on the topic from EVJ and its sister journal, Equine Veterinary Education. His intention is to highlight the significant risk r